Antagonism of cholera enterotoxin by anti-inflammatory agents in the rat.
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001826:Body Fluids / Q000187:drug effects; D001835:Body Weight; D002771:Cholera / Q000503:physiopathology*; D003907:Dexamethasone / Q000627:therapeutic use; D004195:Disease Models, Animal; D004768:Enterotoxins / Q000037:antagonists & inhibitors*; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005260:Female; D007213:Indomethacin / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D010653:Phenylbutazone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D012980:Sodium Salicylate / Q000008:administration & dosage / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D004768:Enterotoxins; D003907:Dexamethasone; D011239:Prednisolone; D010653:Phenylbutazone; D004976:Ethacrynic Acid; D001241:Aspirin; D012980:Sodium Salicylate; D007213:Indomethacin